Monivent AB (XSAT:MONI) Notes Receivable : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Monivent AB Notes Receivable?

Monivent AB's Notes Receivable for the quarter that ended in Mar. 2024 was kr0.00 Mil.

Monivent AB Notes Receivable Historical Data

The historical data trend for Monivent AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monivent AB Notes Receivable Chart

Monivent AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Notes Receivable

Get a 7-Day Free Trial

Monivent AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Notes Receivable	Get a 7-Day Free Trial															-	-	-	-	-

Monivent AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Monivent AB Notes Receivable Related Terms

Thank you for viewing the detailed overview of Monivent AB's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Monivent AB (XSAT:MONI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monivent AB (XSAT:MONI) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Regnbagsgatan 8B, Gothenburg, SWE, SE-417 55

Website

https://www.monivent.se

Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.